Icatibant

Chemical formula: C₅₉H₈₉N₁₉O₁₃S  Molecular mass: 1,304.54 g/mol  PubChem compound: 71364

Therapeutic indications

Icatibant is indicated for:

Hereditary angioedema with C1-esterase-inhibitor deficiency

Population group: only adults (18 - 65 years old)

Icatibant is indicated for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents, with C1-esterase-inhibitor deficiency.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hereditary angioedema with C1-esterase-inhibitor deficiency

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Icatibant is indicated for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adolescents and children aged 2 years and older, with C1-esterase-inhibitor deficiency.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.